A Study of Remitoro in Participants With Recurrent or Refractory Peripheral T Cell Lymphoma and Cutaneous T Cell Lymphoma (All Case Study)
Conditions: Lymphoma, T-cell, Peripheral; Lymphoma, T-cell, Cutaneous Intervention: Drug: Remitoro Sponsor: Eisai Inc. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials